Expression of CD133 correlates with differentiation of human colon cancer cells

33Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CD133 has been identified as a cancer stem cell marker in colon and several other cancers, but its function is still unknown. We examined the CD133 expression in 44 human cancer cell lines, and found five of the 8 positive lines were from colon cancer. The CD133 positive subpopulation of colon cancer cells showed more vigorous growth and lower differentiation. Induction of differentiation reduced the CD133-positive population. Knockdown of CD133 expression in colon cancer cells could not induce cellular differentiation. Care must be taken if CD133 is used as the only marker of cancer stem cells in colon cancer, especially in established cell lines. CD133 negatively correlates with cell differentiation, but it is not a regulator of differentiation. © 2010 Landes Bioscience.

Cite

CITATION STYLE

APA

Feng, H. L., Liu, Y. Q., Yang, L. J., Bian, X. C., Yang, Z. L., Gu, B., … Zhao, X. M. (2010). Expression of CD133 correlates with differentiation of human colon cancer cells. Cancer Biology and Therapy, 9(3), 216–223. https://doi.org/10.4161/cbt.9.3.10664

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free